Skip to main content
. 2022 Jan 12;45(2):145–153. doi: 10.1007/s40264-021-01139-y

Table 1.

Pharmacological profile of selective serotonin reuptake inhibitors (SSRIs) and vortioxetine [13]

SERT inhibition 5HT2C antagonism NET
inhibition
DAT inhibition σ1
agonist
M1 antagonism NOS inhibition H1-antagonist 5HT1A agonist 5HT1B
partial agonist
5HT1D
antagonist
5HT3 antagonist 5HT7 antagonist
Citalopram + +
Escitalopram +
Fluoxetine + + + (only at very high doses)
Fluvoxamine + +
Paroxetine + + + +
Sertraline + + +
Venlafaxine + +
Vortioxetine + + + + + +

SERT serotonin transporter, 5-HT 5-hydroxytryptamine, DAT dopamine transporter, H1 histamine 1 receptor, M1 muscarinic acetylcholine 1 receptor, NET norepinephrine transporter, NOS nitric oxide synthetase, SERT serotonin transporter, DAT dopamine transporter, σ1 sigma 1 receptor, M1 muscarinic acetylcholine 1 receptor, NOS nitric oxide synthetase, H1 histamine 1 receptor, σ1 sigma 1 receptor